Houston Methodist soon will open the Paula and Joseph C. “Rusty” Walter III Tower, a 22-story, $700 million patient tower housing new beds and state-of-the-art technology to better serve the community and the institution’s growing patient population. The nationally-ranked Houston Methodist DeBakey Heart & Vascular Center and Houston Methodist Neurological Institute will move into the new building. Cardiovascular surgeons, cardiologists, …

MiMedx Group announced that it received regulatory approval from the Therapeutics Goods Administration (TGA) in Australia to market and sell a broad array of the Company’s dehydrated Human Amnion/Chorion Membrane (dHACM) products. This includes EpiFix, AmnioFix, EpiBurn, AmnioFix Injectable, and AmnioFix Wrap, among others. MiMedx products are classified as a Biological in Australia and are regulated by the TGA, a …

NuVasive and Siemens Healthineers today announced a strategic partnership focused on technology development, marketing and commercial activities to advance clinical outcomes in minimally invasive spine surgery. NuVasive is an innovation leader in spine health technology, focused on transforming spine surgery with minimally disruptive, predictable and clinically reproducible procedurally-integrated solutions, while Siemens Healthineers offers surgeons a broad portfolio of imaging systems …

Boston Scientific Corporation announced it has signed an agreement to acquire VENITI, Inc., a privately-held company in Fremont, California which has developed and commercialized the VICI VENOUS STENT® System for treating venous obstructive disease. Boston Scientific has been an investor in VENITI since 2016 and currently owns 25 percent of the company. The transaction price for the remaining stake consists of $108 million up-front cash, as …